Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical ...

Basal cell skin cancer, the most common type, can easily be mistaken for a harmless pimple due to its appearance as a ...

Cancers driven by hiccups in RNA processing can’t hide from our immune system, according to new work published today in Cell. A cross-institutional team Fred Hutch Cancer Center and Memorial Sloan ...

Combination treatment of mTNX-1700 (mTFF2-MSA fusion protein) with anti-PD1 antibody was associated with increased survival and decreased metastases in animal models of gastric cancer relative to anti ...

Study shows botensilimab “switches on” the body’s own T-cells to attack a common, treatment-resistant form of colorectal cancer LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader ...

MiNK Therapeutics, Inc., a biopharmaceutical company focused on allogeneic invariant natural killer T (iNKT) cell therapies, announced the publication of a peer-reviewed article in Frontiers in ...

ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...